7-((2-Aminoethyl)amino)-N,N-dimethylbenzo[c][1,2,5]oxadiazole-4-sulfonamide

Catalog No. :
ACOJCB614
CAS No. :
189373-41-9
Molecular Formula :
C10H15N5O3S
Molecular Weight :
285.33

IUPAC Name:7-((2-aminoethyl)amino)-N,N-dimethylbenzo[c][1,2,5]oxadiazole-4-sulfonamide

7-((2-Aminoethyl)amino)-N,N-dimethylbenzo[c][1,2,5]oxadiazole-4-sulfonamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$354.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name7-((2-Aminoethyl)amino)-N,N-dimethylbenzo[c][1,2,5]oxadiazole-4-sulfonamide
IUPAC Name7-((2-aminoethyl)amino)-N,N-dimethylbenzo[c][1,2,5]oxadiazole-4-sulfonamide
MDL No.MFCD01321129
Molecular FormulaC10H15N5O3S
Molecular Weight285.33
SMILESCN(C)S(=O)(=O)C1=CC=C(NCCN)C2=NON=C12
InChI KeyRDMBHRPODMXKHT-UHFFFAOYSA-N
Synonym7-(2-aminoethylamino)-N,N-dimethyl-2,1,3-benzoxadiazole-4-sulfonamide | DBD-ED | 7-(2-Aminoethylamino)-N,N-dimethyl-4-benzofurazansulfonamide | 2,1,3-Benzoxadiazole-4-sulfonamide, 7-[(2-aminoethyl)amino]-N,N-dimethyl- | SCHEMBL15877765 | DBD-ED [=4-(N,N-D
CAS No.189373-41-9
PubChem CID4125780

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACOJCB614 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACOJCB614 route product structure diagram
    ACOJCB614189373-41-9
Inquiry

2. ACOJCB614 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACDOKV094 route compound structure diagram
    ACDOKV09416483-18-4 In Stock
  4. Then
  5. ACOJCB614 route product structure diagram
    ACOJCB614189373-41-9
Inquiry

Comments (0)